Northwest Biotherapeutics Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Northwest Biotherapeutics Inc.

NWBO 0.232

-8.3%

3:58 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Gary Mohilner	10/9/2019 2:56:54 PM
	of 759

Is anyone still following this board. I'm still believing that something will happen by the SNO conference, but I cannot say what it will be. If they have acceptance of their SAP, I believe that unblinded Phase 3 Trial results will be unblinded, but if the SAP is still being discussed with the regulators, all they can do is discuss their plans for bringing the drug through the approval process. Frankly, they have no control of how long the regulators take to reach an agreement with them on a new SAP, and it's possible different regulators will agree to different SAP's. The most important would certainly be the U.S. FDA, but they also are probably the toughest to deal with. It's still my belief that partnership or buyout will occur prior to approval, and perhaps prior to the submission of a BLA which could come late this year, or early next depending on when the SAP is accepted. Gary

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next